Translate   15 hrs

https://www.selleckchem.com/products/yo-01027.html
There were 133 amputations in CREDENCE (3·0% annual event rate) and 187 amputations in CANVAS (1·8% annual event rate), with prior amputation being the strongest predictor of future amputation in both groups. Effects of canagliflozin on amputation risk were significantly different between trials (pheterogeneity 0·02, I2 =82%), but this was not explained by participant or trial differences. There was no evidence that foot disease management protocols instituted during CREDENCE ameliorated amputation risk. Conclusions We identified no ex

  • Like
  • Love
  • HaHa
  • WoW
  • Sad
  • Angry